UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006236
Receipt number R000007372
Scientific Title Verification of the diagnosis and the psychological intervention for individuals with developmental disorders
Date of disclosure of the study information 2011/08/26
Last modified on 2014/12/26 12:46:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the diagnosis and the psychological intervention for individuals with developmental disorders

Acronym

Verification of the diagnosis and the psychological intervention for individuals with developmental disorders

Scientific Title

Verification of the diagnosis and the psychological intervention for individuals with developmental disorders

Scientific Title:Acronym

Verification of the diagnosis and the psychological intervention for individuals with developmental disorders

Region

Japan


Condition

Condition

Autism spectrum disorders

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the psychological intervention for individuals with autism spectrum disorders by structured interview, questionnaire and cognitive function test

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

TAS-20, CISS and ASD questionnaire scores and the percentage of correct response on the MPMR task at post intervention.

Key secondary outcomes

TAS-20, CISS and ASD questionnaire scores and the percentage of correct response on the MPMR task at 12 week follow up and STAI, SPAI, LSAS, CES-D, GAF, WHO QOL 26 scores at the post intervention and 12 week follow up.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Cognitive Behavior Therapy

Interventions/Control_2

waitlist

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

1) ADOS or ADIR with a score above the ASD cut off
2) a full IQ of at least 85 and a verbal IQ of 100 or above (IQ will be evaluated using the WAIS-III)
3) high school graduate or above
4) knowledge of ones diagnosis
5) realization of ones poor emotional self-awareness/ability to express emotion and poor understanding of others emotions and thoughts
6) willingness to participate

Key exclusion criteria

Sever psychiatric complication

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuki Kawakubo

Organization

University of Tokyo Hospital

Division name

Department of Child Neuropsychiatry

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

0358008664

Email

kawakuboyuki@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Miho Kuroda

Organization

Graduate School of Medicine, The University of Tokyo

Division name

Department of Child Neuropsychiatry

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

0358006894

Homepage URL


Email

pr6m-krd@asahi-net.or.jp


Sponsor or person

Institute

Departument of Nueropsychiatry, University of Tokyo Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology
National Center of Neurology and Psychiatry

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Jpapan


Other related organizations

Co-sponsor

National Center of Neurology and Psychiatry

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)、国立精神神経医療研究センター(東京都)


Other administrative information

Date of disclosure of the study information

2011 Year 08 Month 26 Day


Related information

URL releasing protocol

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726296/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 08 Month 26 Day

Date of IRB


Anticipated trial start date

2011 Year 09 Month 01 Day

Last follow-up date

2013 Year 06 Month 30 Day

Date of closure to data entry

2013 Year 06 Month 30 Day

Date trial data considered complete

2014 Year 04 Month 30 Day

Date analysis concluded

2014 Year 06 Month 10 Day


Other

Other related information



Management information

Registered date

2011 Year 08 Month 26 Day

Last modified on

2014 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007372


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name